Antibiotic dosing in obese patients can be a major challenge. In this article, an infectious diseases and critical care pharmacist with significant experience in this area is interviewed and insights on the topic are provided. Interview with: Lina Meng, Pharm.D., BCPS, BCCP Interview By: Timothy P. Gauthier, Pharm.D., BCPS-AQ ID [Last updated: 28 … [Read more...]
MRSA Bloodstream Infection: Vancomycin, Daptomycin or Other?
Should MRSA bloodstream infection be treated with vancomycin, daptomycin or something else? In this article an infectious diseases pharmacist with research and clinical experience in the area provides insights on the pharmacologic options for MRSA bloodstream infection. Authored By: Kimberly Claeys, Pharm.D., BCPS [Last Updated 26 November … [Read more...]
Common Antibiotics Flagged For Debilitating Toxicities
In May 2016 and July 2016 the United States Food and Drug Administration (FDA) issued safety alerts regarding the use of fluoroquinolone antibiotics. This includes ciprofloxacin, levofloxacin, moxifloxacin, gemifloxacin and oflaxacin. The alerts are summarized and the topic is discussed here. Authored By: Timothy P. Gauthier, Pharm.D., BCPS-AQ … [Read more...]
Inappropriate Antibiotic Use In Ambulatory Care: A Pharmacist’s Perspective
In this interview researcher and pharmacist Dr. Katie Suda discusses work she and her colleagues published in the May 2016 issue of the Journal of the American Medical Association (JAMA). This publication has garnered considerable public attention after finding an alarming rate of inappropriate antibiotic use in the ambulatory care setting. Interview … [Read more...]
